Threat, hostility and violence in childhood and later psychotic disorder: population-based case-control study.


Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 12 8 2020
medline: 7 4 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

A growing body of research suggests that childhood adversities are associated with later psychosis, broadly defined. However, there remain several gaps and unanswered questions. Most studies are of low-level psychotic experiences and findings cannot necessarily be extrapolated to psychotic disorders. Further, few studies have examined the effects of more fine-grained dimensions of adversity such as type, timing and severity. Using detailed data from the Childhood Adversity and Psychosis (CAPsy) study, we sought to address these gaps and examine in detail associations between a range of childhood adversities and psychotic disorder. CAPsy is population-based first-episode psychosis case-control study in the UK. In a sample of 374 cases and 301 controls, we collected extensive data on childhood adversities, in particular household discord, various forms of abuse and bullying, and putative confounders, including family history of psychotic disorder, using validated, semi-structured instruments. We found strong evidence that all forms of childhood adversity were associated with around a two- to fourfold increased odds of psychotic disorder and that exposure to multiple adversities was associated with a linear increase in odds. We further found that severe forms of adversity, i.e. involving threat, hostility and violence, were most strongly associated with increased odds of disorder. More tentatively, we found that some adversities (e.g. bullying, sexual abuse) were more strongly associated with psychotic disorder if first occurrence was in adolescence. Our findings extend previous research on childhood adversity and suggest a degree of specificity for severe adversities involving threat, hostility and violence.

Sections du résumé

BACKGROUND
A growing body of research suggests that childhood adversities are associated with later psychosis, broadly defined. However, there remain several gaps and unanswered questions. Most studies are of low-level psychotic experiences and findings cannot necessarily be extrapolated to psychotic disorders. Further, few studies have examined the effects of more fine-grained dimensions of adversity such as type, timing and severity.
AIMS
Using detailed data from the Childhood Adversity and Psychosis (CAPsy) study, we sought to address these gaps and examine in detail associations between a range of childhood adversities and psychotic disorder.
METHOD
CAPsy is population-based first-episode psychosis case-control study in the UK. In a sample of 374 cases and 301 controls, we collected extensive data on childhood adversities, in particular household discord, various forms of abuse and bullying, and putative confounders, including family history of psychotic disorder, using validated, semi-structured instruments.
RESULTS
We found strong evidence that all forms of childhood adversity were associated with around a two- to fourfold increased odds of psychotic disorder and that exposure to multiple adversities was associated with a linear increase in odds. We further found that severe forms of adversity, i.e. involving threat, hostility and violence, were most strongly associated with increased odds of disorder. More tentatively, we found that some adversities (e.g. bullying, sexual abuse) were more strongly associated with psychotic disorder if first occurrence was in adolescence.
CONCLUSIONS
Our findings extend previous research on childhood adversity and suggest a degree of specificity for severe adversities involving threat, hostility and violence.

Identifiants

pubmed: 32778182
doi: 10.1192/bjp.2020.133
pii: S0007125020001336
pmc: PMC7525109
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

575-582

Subventions

Organisme : Medical Research Council
ID : MR/S003444/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT087417
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029488/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/603
Pays : United Kingdom
Organisme : MRF
ID : MRF_C0439
Pays : United Kingdom

Références

Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Epidemiol Psichiatr Soc. 2009 Jul-Sep;18(3):221-8
pubmed: 20034200
Pediatrics. 2006 Jul;118(1):130-8
pubmed: 16818558
Schizophr Res. 2005 Dec 1;80(1):117-30
pubmed: 15978778
Schizophr Bull. 2012 Jun;38(4):672-5
pubmed: 22837349
J Psychiatr Res. 2018 Jan;96:57-64
pubmed: 28965006
J Child Psychol Psychiatry. 1994 Nov;35(8):1419-35
pubmed: 7868637
Psychol Med. 2017 May;47(7):1230-1245
pubmed: 28065209
J Abnorm Child Psychol. 2011 Apr;39(3):379-87
pubmed: 20938734
Psychol Med. 1995 Jan;25(1):7-21
pubmed: 7792364
Arch Gen Psychiatry. 2010 Nov;67(11):1114-9
pubmed: 21041612
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
J Child Psychol Psychiatry. 1997 Mar;38(3):365-74
pubmed: 9232482
Psychol Med. 2013 Oct;43(10):2077-86
pubmed: 23302254
Schizophr Res. 2012 May;137(1-3):73-9
pubmed: 22353995
J Psychiatr Res. 2020 Apr;123:145-150
pubmed: 32065950
Schizophr Bull. 2020 Jul 8;46(4):814-822
pubmed: 32047940
World Psychiatry. 2016 Jun;15(2):93-102
pubmed: 27265690
Arch Gen Psychiatry. 2011 Aug;68(8):838-44
pubmed: 21810647
Lancet Psychiatry. 2016 Jul;3(7):685-92
pubmed: 27371990
Am J Psychiatry. 2011 Jan;168(1):65-72
pubmed: 20952460
Schizophr Bull. 2014 Jan;40(1):161-8
pubmed: 23970556
Schizophr Res. 2013 Oct;150(1):169-75
pubmed: 23891482
Lancet. 2014 May 10;383(9929):1677-1687
pubmed: 24315522
Br J Psychiatry. 1996 Jul;169(1):58-63
pubmed: 8818369
Br J Psychiatry. 2009 Apr;194(4):319-25
pubmed: 19336782
Schizophr Bull. 2011 May;37(3):546-53
pubmed: 19776204
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1011-22
pubmed: 24919446
Psychoneuroendocrinology. 2013 May;38(5):603-11
pubmed: 23369532
BJPsych Open. 2015 Jun 23;1(1):6-13
pubmed: 27703716
Psychol Med Monogr Suppl. 1992;20:1-97
pubmed: 1565705
Lancet Public Health. 2017 Aug;2(8):e356-e366
pubmed: 29253477
Am J Psychiatry. 2011 Dec;168(12):1286-94
pubmed: 21955935

Auteurs

Craig Morgan (C)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London; and Economic and Social Research Council (ESRC) Centre for Society and Mental Health, King's College London, UK.

Charlotte Gayer-Anderson (C)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and Economic and Social Research Council (ESRC) Centre for Society and Mental Health, King's College London, UK.

Stephanie Beards (S)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Kathryn Hubbard (K)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Valeria Mondelli (V)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, UK.

Marta Di Forti (M)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Robin M Murray (RM)

FRS, Institute of Psychiatry, Psychology & Neuroscience, King's College London; and National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, UK.

Carmine Pariante (C)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, UK.

Paola Dazzan (P)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, UK.

Thomas J Craig (TJ)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Ulrich Reininghaus (U)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and Economic and Social Research Council (ESRC) Centre for Society and Mental Health, King's College London, UK.

Helen L Fisher (HL)

Institute of Psychiatry, Psychology & Neuroscience, King's College London; and Economic and Social Research Council (ESRC) Centre for Society and Mental Health, King's College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH